Document is current
Any future updates will be listed below
-
Authors
Zhou, Benjamin
Uppuluri, Aditya
Zarbin, Marco A.
Bhagat, Neelakshi https://orcid.org/0000-0003-2187-3145
- License Information
-
More Information
Article History
Received: 30 August 2022
Revised: 12 January 2023
Accepted: 26 January 2023
First Online: 8 February 2023
Declarations
:
: This article does not contain any studies with human participants or animals performed by any of the authors.
: Author Dr. Marco A. Zarbin is a paid consultant for Boehringer Ingelheim (Ingelheim am Rhein, Germany), Frequency Therapeutics (Lexington, MA), Genentech/Roche (South San Francisco, CA), Iduna (Boston, MA), Iveric Bio (Cranbury, NJ), Life Biosciences (Boston, MA), Novartis Pharma AG (Basel, Switzerland), Ophthotech, Perfuse Therapeutics (San Francisco, CA), Selphagy (Boston, MA), and is a cofounder of NVasc (Atherton, CA). All other authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.
